Ad
CLSN Short Information Celsion Corporation
home / stock / clsn / clsn short
Short Information | Celsion Corporation (NASDAQ:CLSN)
| Twenty Trading Day Totals | |
|---|---|
| Total Shorted Volume | 167,709 |
| Total Actual Volume | 865,355 |
| Short Trends | |
|---|---|
| Cover Days | 18 |
| Short Days | 0 |
| No Change Days | 2 |
| Averages | |
|---|---|
| Average Short Volume | 8,385 |
| Average Short Percentage | 19.06% |
Is there a CLSN Short Squeeze or Breakout about to happen?
See the CLSN Short Analysis for free Sign up or Login
Powered by Squeeze Report
CLSN Twenty Trading Day's Volume to Short Volume Chart
CLSN Twenty Trading Day Price Chart
CLSN Short Data Results Days
| Date | Open | Close | High | Low | Total Volume | Short Volume | Short Percentage |
|---|---|---|---|---|---|---|---|
| 09-20-2022 | $1.96 | $1.96 | $1.9999 | $1.9286 | 57,866 | 14,315 | 24.74% |
| 09-19-2022 | $2.01 | $1.96 | $2.02 | $1.93 | 45,891 | 12,231 | 26.65% |
| 09-16-2022 | $2.03 | $2.04 | $2.11 | $2.02 | 16,888 | 1,287 | 7.62% |
| 09-15-2022 | $2.05 | $2.08 | $2.29 | $2.02 | 33,247 | 5,722 | 17.21% |
| 09-14-2022 | $2.1 | $2.07 | $2.13 | $2.02 | 20,743 | 7,776 | 37.49% |
| 09-13-2022 | $2.24 | $2.1 | $2.2986 | $2.07 | 36,688 | 5,741 | 15.65% |
| 09-12-2022 | $2.23 | $2.22 | $2.2893 | $2.2 | 32,807 | 7,063 | 21.53% |
| 09-09-2022 | $2.19 | $2.2 | $2.2 | $2.105 | 37,269 | 6,587 | 17.67% |
| 09-08-2022 | $2.1 | $2.1466 | $2.15 | $2.06 | 22,274 | 2,980 | 13.38% |
| 09-07-2022 | $1.93 | $2.1 | $2.17 | $1.93 | 93,066 | 23,981 | 25.77% |
| 09-06-2022 | $2.05 | $1.9501 | $2.05 | $1.91 | 30,872 | 13,981 | 45.29% |
| 09-01-2022 | $2.09 | $2.0895 | $2.2 | $1.98 | 93,553 | 19,535 | 20.88% |
| 08-31-2022 | $2.3099 | $2.13 | $2.33 | $2.13 | 34,892 | 977 | 2.8% |
| 08-30-2022 | $2.29 | $2.24 | $2.3099 | $2.2 | 29,626 | 1,387 | 4.68% |
| 08-29-2022 | $2.25 | $2.25 | $2.321 | $2.22 | 26,896 | 7,905 | 29.39% |
| 08-26-2022 | $2.49 | $2.2699 | $2.56 | $2.26 | 69,275 | 5,691 | 8.22% |
| 08-24-2022 | $2.4 | $2.4195 | $2.45 | $2.32 | 57,105 | 8,850 | 15.5% |
| 08-23-2022 | $2.35 | $2.37 | $2.39 | $2.3 | 33,833 | 4,537 | 13.41% |
| 08-22-2022 | $2.26 | $2.32 | $2.36 | $2.26 | 68,246 | 14,052 | 20.59% |
| 08-18-2022 | $2.45 | $2.419 | $2.47 | $2.3728 | 24,318 | 3,111 | 12.79% |
News, Short Squeeze, Breakout and More Instantly...
Ad
-
New name reflects the evolution of the Company’s business focus and its commitment to immunotherapies and vaccines LAWRENCEVILLE, N.J., Sept. 19, 2022 (GLOBE NEWSWIRE) -- Celsion Corporation (NASDAQ: CLSN ), a clinical-stage drug development company, today announced ...
-
110 Patients Enrolled in Study Comparing Novel Gene-Mediated Immunotherapy plus Neoadjuvant Chemotherapy versus Neoadjuvant Chemotherapy Alone LAWRENCEVILLE, N.J., Sept. 15, 2022 (GLOBE NEWSWIRE) -- Celsion Corporation (NASDAQ: CLSN ), a clinical-stage company focused on DNA-ba...
-
LAWRENCEVILLE, N.J., Sept. 12, 2022 (GLOBE NEWSWIRE) -- Celsion Corporation (NASDAQ: CLSN) , a clinical-stage drug development company, announces that Dr. Corinne Le Goff, President and Chief Executive Officer, will present a company overview at the H.C. Wainwright 24 th An...